AB079. Upregulation of DEPDC1B correlates with tumor progression and predicts a poor prognosis in prostate cancer

One of the challenges in prostate cancer (PCa) treatment is lacking biomarkers that could accurately predict PCa progression. The most widely used biomarkers for PCa was prostate-specific antigen (PSA) level. However, PSA testing had low specificity for prostate cancer due to some other kinds of dis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transl Androl Urol
Prif Awduron: Cui, Feilun, Hu, Jiangpeng, Tan, Jian, Tang, Huaming
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AME Publishing Company 2017
Pynciau:
Printed Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5565543/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2017.s079
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg